premargin

Element List	Explanation
Introduction	The Board of Directors of Middle East Pharmaceutical Industries Company resolved on 19-09-1447H Corresponding to 08-03-2026 to distribute interim cash dividends to the company’s shareholders for the second half of 2025.
Date of the board’s decision	2026-03-08 Corresponding to 1447-09-19
The Total amount distributed	SAR 26,400,000
Number of Shares Eligible for Dividends	Shares 20,000,000
Dividend per share	SAR 1.32
Percentage of Dividend to the Share Par Value (%)	13.2
Eligibility date	2026-03-29 Corresponding to 1447-10-10
Distribution Date	2026-04-07 Corresponding to 1447-10-19
The name of other official authorities and the details of their non-refusal to the recommendation or decision	N/A
Additional Information	We would like to draw the attention of non-resident foreign investors to the fact that the cash distributions are transferred through the resident financial intermediary, and when transferred or credited in his account, are subject to a withholding tax of 5% in accordance with the provisions of Article (68) of the income tax law and Article (63) of its implementing regulations. In case of any inquiries, please contact the Investor Relations Department via: Phone: 920010564 Ext: 3374 Email: investor.relations@avalon.com.sa

Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the second half of 2025.